Barclays Lowers Oracle Price Target to $230

Mar 9, 2026 1 min read Reproduced verbatim

Rating: Buy
Price target: $230; from $310
Implied upside: +50%; vs $152.96 prior close

Barclays analyst Raimo Lenschow lowered the price target on Oracle (NYSE: ORCL) to $230.00 (from $310.00) while maintaining an Overweight rating.

Disclaimer
The price target and rating on this page are the opinion of the issuing research firm and its analyst, not of Price Target. This page is published for informational purposes only and is not investment advice, a recommendation, or an offer to buy or sell any security. Past performance does not guarantee future results. Consider your own circumstances and consult a licensed financial adviser before making investment decisions.

This research note is reproduced verbatim from the issuing firm. Price Target never edits, paraphrases or alters analysts’ words — we only republish them in one place.

Tracking this call

Since this note−5% ORCL $152.96 → $144.77 (Oct 7) · moving away from the target

This call at 6 months✓ Target reached on Jun 1, 2026, 3 months after the note.

Firm track recordBarclays reached 80% of its 40 scored targets within six months (#4 of 31 firms); on Oracle, 2 of 3. Accuracy ranking →

Barclays on Oracle · target history

Feb 2, 2026 · $310 · Buy Mar 9, 2026 · $230 · Buy · this note Mar 11, 2026 · $240 · Buy Jun 8, 2026 · $240 · Buy Jun 11, 2026 · $250 · Buy Sep 11, 2026 · $252 · Buy

Tracking this call

More from Barclays on Oracle

Other Oracle notes